Position in ROIV
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$25,266,548
+$6,471,600 QoQ
Shares Held
713,946
+5.2% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#77
of 494 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ROIV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. ROIV ranks #8 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
This page
|
713,946 | $25,266,548 |
All Filings in ROIV
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $25,266,548 | 713,946 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $18,794,948 | 678,518 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $13,919,703 | 641,461 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $579,312 | 38,289 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $482,468 | 42,810 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $331,698 | 32,874 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $318,475 | 26,921 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||